Testing effectiveness (Phase 2)Study completedNCT03126019What this trial is testingINCB050465 in Relapsed or Refractory Follicular LymphomaWho this might be right forLymphoma Incyte Corporation 126
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)WithdrawnNCT01652014What this trial is testingSingle or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Active Not RecruitingNCT05660967What this trial is testingSubcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma Genmab 111
Testing effectiveness (Phase 2)Study completedNCT01839916What this trial is testingDonor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more University of Chicago 77
Early research (Phase 1)UnknownNCT00008021What this trial is testingMonoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma University of California, Davis
Testing effectiveness (Phase 2)Study completedNCT01939899What this trial is testingPhase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular LymphomaWho this might be right forFollicular Lymphoma Millennium Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT00021372What this trial is testingPaclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Fox Chase Cancer Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT07473167What this trial is testingStudy of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma PatientsWho this might be right forRelapsed Large B-cell LymphomaRefractory Large B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)+3 more TICAROS Co., Ltd. 98
Testing effectiveness (Phase 2)Ended earlyNCT00265928What this trial is testingBortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Virginia 46
Testing effectiveness (Phase 2)Study completedNCT02038946What this trial is testingStudy of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)Who this might be right forLymphoma Bristol-Myers Squibb 116
Testing effectiveness (Phase 2)Study completedNCT00546377What this trial is testingPentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell CancerWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center 50
Not applicableEnded earlyNCT00726830What this trial is testingMethadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more M.D. Anderson Cancer Center 1
Early research (Phase 1)Study completedNCT00049712What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT01129193What this trial is testingAR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more Amir Mortazavi 44
Testing effectiveness (Phase 2)Study completedNCT01397825What this trial is testingMLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- VincristineWho this might be right forDiffuse Large B-Cell LymphomaTransformed Follicular LymphomaMantle Cell Lymphoma+1 more Millennium Pharmaceuticals, Inc. 45
Early research (Phase 1)Study completedNCT01582932What this trial is testingEvaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque PsoriasisWho this might be right forPsoriasis Mayne Pharma International Pty Ltd 36
Testing effectiveness (Phase 2)Ended earlyNCT05360238What this trial is testingStudy to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLLWho this might be right forFollicular B-cell Non-Hodgkin's LymphomaMantle Cell Lymphoma RecurrentMantle Cell Lymphoma Refractory+5 more Mustang Bio 20
Testing effectiveness (Phase 2)UnknownNCT00036426What this trial is testingIdiotype Vaccine for Low-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma, Low-Grade Favrille 22